SEK 33,9 million from Cancerfonden to researchers at Labmed

In Cancerfonden's latest call, SEK 33,9 million was awarded to 12 researchers at the Department of Laboratory Medicine for the years 2027-2029.
Mikael Björnstedt, Professor
Title: "Integrated Precision Stratification and Selenium-mediated Targeted Redox Therapy in Resistant Tumors with Special Emphasis on HPB cancers"
Project grant, total amount: SEK 3 750 000
Jonas Fuxe, Professor
Title: "Cancer cell plasticity as a driver of immune evasion and lymphatic metastasis"
Project grant, total amount: SEK 3 750 000
Yizhou Hu, Researcher
Title: "Defining and targeting the stromal lipid niche in high-risk neuroblastoma through spatial MultiOmics"
Project grant, total amount: SEK 3 000 000
Andri Lemarquis, Assistant Professor
Title: "The role of recent thymic emigrants in tumor control"
Project grant, total amount: SEK 3 000 000
Magdalini Lourda, Docent
Title: "LUMEN: Liquid biopsy and organoid modelling to understand and predict neurodegeneration in Langerhans cell histiocytosis"
Project grant, total amount: SEK 3 000 000
Helen Kaipe, Docent
Title: "Combining tumorreactive T cells and CAF targeting to improve immunotherapy in pancreatic cancer"
Project grant, total amount: SEK 3 000 000
Anders Mutvei, Docent
Title: "Lysosome abundance and organization in cancer"
Project grant, total amount: SEK 3 000 000
Dhifaf Sarhan, Docent
Title: "Programming adaptive NK cell memory for treatment durability and relapse prevention in high-grade serous ovarian cancer"
Project grant, total amount: SEK 3 000 000
Matti Sällberg, Professor
Title: "Genetic vaccines and immune-based therapies to prevent severe liver disease and cancer caused by chronic viral hepatitis: Therapy development and models"
Project grant, total amount: SEK 3 000 000
Oscar Wiklander, Assistant Professor
Title: "Extracellular Vesicles as an Integrated Platform for Precision-Guided Cancer Therapy"
Project grant, total amount: SEK 3 000 000
Peter Bergman, Professor
Title: "Can a new drug reduce intestinal damage during chemotherapy treatment by activating the natural immunity in the intestinal mucosa?"
Project grant, total amount: SEK 1 600 000
Stephan Mielke, Professor
Title: "Early risk stratification in CAR T-cell therapy to improve safety, access and outcome"
Project grant, total amount: SEK 800 000